Cabozantinib Plus Pembrolizumab for Recurrent, Persistent and/or Metastatic Cervical Cancer
Clinical trial NCT04230954 · TERMINATED
Trial details
- NCT number
- NCT04230954
- Sponsor
- University of South Alabama
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-16
- Primary completion
- 2022-02-16
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.